The Journal of Rheumatology · 2012 · 36 citations · 18 references
MedicineOrthopedic SurgeryPharmacotherapyOrthopedicsPain ManagementPain MedicineBone HealthFracture RiskOsteoporosisOsteoporosis PharmacotherapyPain OutcomesVertebral FracturesFracturesGlucocorticoid PharmacologyGlucocorticoid SignalingObservational Study EvaluationOsteoporosis EpidemiologyOsteoporosis In WomenPostmenopausal Osteoporosis TreatmentRepeated Measures Analysis
OBJECTIVE: To describe clinical fracture rates, back pain, and health-related quality of life (HRQOL) in postmenopausal women with osteoporosis who are receiving glucocorticoids (GC), during a 36-month study of teriparatide treatment for up to 18 months, with an additional 18-month followup period when patients were receiving other osteoporosis medications. METHODS: A prospective, multinational, observational study. Data for clinical fractures, back pain (by visual analog scale; VAS) and HRQOL (by EQ-5D) were collected over 36 months. Fracture data were summarized in 6-month segments and analyzed using logistic regression with repeated measures. Changes from baseline in back pain VAS and EQ-VAS were analyzed. RESULTS: Of 1581 enrolled women with followup data, 294 (18.6%) had antecedents of GC use. Of these, 49 (16.7%) patients sustained a total of 69 fractures during the 36-month study period. Adjusted odds of fracture were significantly decreased during the last year of followup compared with the first 6 months of teriparatide treatment: an 81% decrease in the 24 to < 30-month period (p < 0.05), and an 89% decrease in the 30 to < 36-month period (p < 0.05). There were significant reductions in back pain and improvements in HRQOL in both groups of GC users and nonusers. CONCLUSION: Postmenopausal women with severe osteoporosis receiving GC, who were treated with teriparatide for up to 18 months, showed a reduced incidence of clinical fractures during the third year while receiving sequential osteoporosis treatments compared with the first 6 months, together with reduced back pain and improved HRQOL. Our results should be interpreted in the context of an uncontrolled observational study in a routine clinical setting.
18
Choice Reviews Online · 1990 · 35.7K citations
Elizabeth Shane, David B. Burr, Peter R. Ebeling et al. · Journal of Bone and Mineral Research · 2010 · 1.1K citations